๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐๐ฑ๐ข๐๐๐ญ๐ข๐ฏ๐ ๐๐ญ๐ซ๐๐ฌ๐ฌ ๐๐ฌ๐ฌ๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐๐-๐๐๐๐)
๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐- https://lnkd.in/dt-M8XA5
The North American market revenue for oxidative stress assays is estimated to reach USD 490 million in 2025 and is forecasted to grow to USD 950 million by 2035. The CAGR is supported by higher adoption in personalized medicine and environmental monitoring. Notably, a steady upwards trend is observed from 2020, as major players expand their portfolio and increase access through digital channels.
Key Drivers
Rising prevalence of chronic and lifestyle-related diseases such as cancer and cardiovascular disorders is propelling demand for oxidative stress assays; for instance, Thermo Fisher Scientific expanded its diagnostics offerings in 2024, addressing this need.
Technological advancements in assay platforms, notably the integration of automation and high-throughput screening by BioVision Inc. in 2024, are making these assays more accessible and efficient.
Key Trends
Accelerated adoption of multiplex assays and integrated platforms is streamlining laboratory workflows, as seen with Abcam plc’s launch of next-generation multiplex oxidative stress kits in 2024.
Growth in direct-to-consumer testing and online assay purchases, highlighted by Qiagen NV’s increased e-commerce activity and single-use assay sales in 2024.
Market Insights & Segmentation
Type (Consumables, Instruments, Services),
Application (Research, Clinical Diagnostics, Drug Discovery, Food Testing, Environmental Testing, Others),
Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors, E-commerce, Others),
Technology (ELISA, Chromatography, Flow Cytometry, Spectrophotometry, Chemiluminescence, Others),
Organization Size (Small, Medium, Large)
Key Market Companies
Thermo Fisher Scientific, Merck KGaA, Abcam plc, Cell Biolabs Inc., Enzo Life Sciences, Cayman Chemical Company, Oxford Biomedical Research, BioVision Inc., Promega Corporation, Oxis International Inc., Randox Laboratories, Eagle Biosciences, Qiagen NV, Dojindo Molecular Technologies, Tecan Group Ltd.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ- https://lnkd.in/dGMB32Pm
๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐- https://lnkd.in/dt-M8XA5
The North American market revenue for oxidative stress assays is estimated to reach USD 490 million in 2025 and is forecasted to grow to USD 950 million by 2035. The CAGR is supported by higher adoption in personalized medicine and environmental monitoring. Notably, a steady upwards trend is observed from 2020, as major players expand their portfolio and increase access through digital channels.
Key Drivers
Rising prevalence of chronic and lifestyle-related diseases such as cancer and cardiovascular disorders is propelling demand for oxidative stress assays; for instance, Thermo Fisher Scientific expanded its diagnostics offerings in 2024, addressing this need.
Technological advancements in assay platforms, notably the integration of automation and high-throughput screening by BioVision Inc. in 2024, are making these assays more accessible and efficient.
Key Trends
Accelerated adoption of multiplex assays and integrated platforms is streamlining laboratory workflows, as seen with Abcam plc’s launch of next-generation multiplex oxidative stress kits in 2024.
Growth in direct-to-consumer testing and online assay purchases, highlighted by Qiagen NV’s increased e-commerce activity and single-use assay sales in 2024.
Market Insights & Segmentation
Type (Consumables, Instruments, Services),
Application (Research, Clinical Diagnostics, Drug Discovery, Food Testing, Environmental Testing, Others),
Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors, E-commerce, Others),
Technology (ELISA, Chromatography, Flow Cytometry, Spectrophotometry, Chemiluminescence, Others),
Organization Size (Small, Medium, Large)
Key Market Companies
Thermo Fisher Scientific, Merck KGaA, Abcam plc, Cell Biolabs Inc., Enzo Life Sciences, Cayman Chemical Company, Oxford Biomedical Research, BioVision Inc., Promega Corporation, Oxis International Inc., Randox Laboratories, Eagle Biosciences, Qiagen NV, Dojindo Molecular Technologies, Tecan Group Ltd.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ- https://lnkd.in/dGMB32Pm
323 Views
